Pyrrolidinohydroquinazolines -: a novel class of CCR3 modulators

被引:37
作者
Anderskewitz, R [1 ]
Bauer, R [1 ]
Bodenbach, G [1 ]
Gester, D [1 ]
Gramlich, B [1 ]
Morschhäuser, G [1 ]
Birke, FW [1 ]
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, D-88397 Biberach Riss, Germany
关键词
CCR3; eotaxin; antagonist; agonist;
D O I
10.1016/j.bmcl.2004.11.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of CCR3 modulators is described. Starting with lead compound 4a (K-i: 110 nM), which turned out to be all antagonist of eotaxin at the CCR3 receptor, further optimization led to compound 8b (K-i: 28 nM), which surprisingly proved to be an agonist. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:669 / 673
页数:5
相关论文
共 21 条
[1]   Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists [J].
Bryan, SA ;
Jose, PJ ;
Topping, JR ;
Wilhelm, R ;
Soderberg, C ;
Kertesz, D ;
Barnes, PJ ;
Williams, TJ ;
Hansel, TT ;
Sabroe, I .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (12) :1602-1609
[2]   CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN EOSINOPHIL CC-CHEMOKINE RECEPTOR [J].
COMBADIERE, C ;
AHUJA, SK ;
MURPHY, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16491-16494
[3]  
Corrigan C, 2000, Curr Opin Investig Drugs, V1, P321
[4]   Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists [J].
De Lucca, GV ;
Kim, UT ;
Johnson, C ;
Vargo, BJ ;
Welch, PK ;
Covington, M ;
Davies, P ;
Solomon, KA ;
Newton, RC ;
Trainor, GL ;
Decicco, CP ;
Ko, SK .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3794-3804
[5]  
DICKORE K, 1980, Patent No. 4240820
[6]  
DUPONT PHARM CO, 2000, Patent No. [00035451, 0035451]
[7]   2-AMINO-THIOPHENE AUS METHYLENAKTIVEN NITRILEN CARBONYLVERBINDUNGEN UND SCHWEFEL [J].
GEWALD, K ;
SCHINKE, E ;
BOTTCHER, H .
CHEMISCHE BERICHTE-RECUEIL, 1966, 99 (01) :94-&
[8]  
GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
[9]   The structure of vasicine. II. Synthesis of desoxyvasicine [J].
Hanford, WE ;
Adams, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1935, 57 (01) :921-924
[10]   Chemokine receptor usage by human eosinophils - The importance of CCR3 demonstrated using an antagonistic monoclonal antibody [J].
Heath, H ;
Qin, SX ;
Rao, P ;
Wu, LJ ;
LaRosa, G ;
Kassam, N ;
Ponath, PD ;
Mackay, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) :178-184